These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28473986)

  • 1. A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples.
    Gupta S; Taylor T; Patterson A; Liang B; Bullard J; Sandstrom P; Van Domselaar G; Ji H
    Biomed Res Int; 2017; 2017():4979252. PubMed ID: 28473986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal profiling of HIV-1 pol for genotypic study and resistance analysis across subtypes.
    Nie T; Detorio M; Schinazi RF
    Antivir Ther; 2011; 16(8):1267-75. PubMed ID: 22155908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.
    Vardhanabhuti S; Taiwo B; Kuritzkes DR; Eron JJ; Bosch RJ
    Antivir Ther; 2015; 20(1):73-6. PubMed ID: 24699164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.
    Gonzalez-Serna A; Min JE; Woods C; Chan D; Lima VD; Montaner JS; Harrigan PR; Swenson LC
    Clin Infect Dis; 2014 Apr; 58(8):1165-73. PubMed ID: 24429436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Dried Plasma Spots for HIV-1 Viral Load Determination and Drug Resistance Genotyping in Mexican Patients.
    Rodriguez-Auad JP; Rojas-Montes O; Maldonado-Rodriguez A; Alvarez-Muñoz MT; Muñoz O; Torres-Ibarra R; Vazquez-Rosales G; Lira R
    Biomed Res Int; 2015; 2015():240407. PubMed ID: 26779533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.
    Kantor R; DeLong A; Schreier L; Reitsma M; Kemboi E; Orido M; Obonge S; Boinett R; Rono M; Emonyi W; Brooks K; Coetzer M; Buziba N; Hogan J; Diero L
    AIDS; 2018 Nov; 32(17):2485-2496. PubMed ID: 30134290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino Acid Prevalence of HIV-1
    Tzou PL; Rhee SY; Shafer RW
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):924-929. PubMed ID: 31317771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences.
    Tzou PL; Kosakovsky Pond SL; Avila-Rios S; Holmes SP; Kantor R; Shafer RW
    PLoS One; 2020; 15(2):e0225352. PubMed ID: 32102090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
    Arora SK; Gupta S; Toor JS; Singla A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.
    Budayanti NS; Merati TP; Bela B; Mahardika GN
    Curr HIV Res; 2018; 16(5):374-382. PubMed ID: 30714528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
    Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
    JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of antiretroviral drug resistance in treatment-naive injecting drug users infected with HIV-1 in Guangzhou, 2008-2015].
    Xu LQ; Han ZG; Zhang YL; Wu H; Gao K; Li QM; Xu HF; Cai YS; Xia Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):196-201. PubMed ID: 30744272
    [No Abstract]   [Full Text] [Related]  

  • 18. Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.
    Santoro MM; Fabeni L; Armenia D; Alteri C; Di Pinto D; Forbici F; Bertoli A; Di Carlo D; Gori C; Carta S; Fedele V; D'Arrigo R; Berno G; Ammassari A; Pinnetti C; Nicastri E; Latini A; Tommasi C; Boumis E; Petrosillo N; D'Offizi G; Andreoni M; Ceccherini-Silberstein F; Antinori A; Perno CF
    Clin Infect Dis; 2014 Apr; 58(8):1156-64. PubMed ID: 24429430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic silica extraction for low-viremia human immunodeficiency virus type 1 genotyping.
    McClernon DR; Ramsey E; Clair MS
    J Clin Microbiol; 2007 Feb; 45(2):572-4. PubMed ID: 17122019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.
    Mens H; Kearney M; Wiegand A; Shao W; Schønning K; Gerstoft J; Obel N; Maldarelli F; Mellors JW; Benfield T; Coffin JM
    J Virol; 2010 Dec; 84(24):12971-81. PubMed ID: 20926564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.